Ledger.Open graph →
SEC Form D · Amendment · filed April 28, 2021

CND Life Sciences, Inc

Offering
$2.9M
Sold
$2.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHOENIX, AZ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Todd J. Levine · Paradise Valley, AZDirectorChristopher J. Gibbons · Brookline, MADirectorPeter J. Harris · Brookline, MADirectorRichard J. Morello · Atlanta, GAExec · DirectorRoy J. Freeman · Brookline, MADirectorGCR CJ Master LLC · Sacramento, CADirectorAlex Appleton · London, United KingdomDirectorMatthew Shaw · London, United KingdomDirectorC River LLC · Sacramento, CADirectorHaakon Overli · London, United KingdomExec · DirectorTodd Sachse · Detroit, MIExec · DirectorRichard Broder · Detroit, MIDirectorHarvey Koo · San Francisco, CADirectorMerredith Treaster · San Francisco, CADirectorCheryl R. Zabala · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗